Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer.

Watanabe D, Fujii H, Matsuhashi N, Iihara H, Yamada Y, Ishihara T, Takahashi T, Yoshida K, Suzuki A.

Anticancer Res. 2020 Apr;40(4):2379-2386. doi: 10.21873/anticanres.14207.

PMID:
32234941
2.

[Good's syndrome developing hemophagocytic lymphohistiocytosis following thymectomy].

Yamada M, Yoshida M, Oiwa S, Watanabe D, Saga J, Yamada S, Ono M, Abe T, Fujii S, Maeda M, Fujita M, Iyama S, Kato J.

Rinsho Ketsueki. 2020;61(3):268-273. doi: 10.11406/rinketsu.61.268. Japanese.

PMID:
32224589
3.

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.

Fujii H, Matsuhashi N, Kitahora M, Takahashi T, Hirose C, Iihara H, Yamada Y, Watanabe D, Ishihara T, Suzuki A, Yoshida K.

Oncologist. 2020 Mar;25(3):e469-e476. doi: 10.1634/theoncologist.2019-0541. Epub 2019 Nov 20.

4.

Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.

Watanabe D, Fujii H, Yamada Y, Iihara H, Ishihara T, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A.

Anticancer Res. 2020 Jan;40(1):299-304. doi: 10.21873/anticanres.13953.

PMID:
31892580
5.

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.

Fujii H, Matsuhashi N, Kitahora M, Takahashi T, Hirose C, Iihara H, Yamada Y, Watanabe D, Ishihara T, Suzuki A, Yoshida K.

Oncologist. 2019 Nov 20. pii: theoncologist.2019-0541. doi: 10.1634/theoncologist.2019-0541. [Epub ahead of print]

6.

High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.

Yamada Y, Fujii H, Ohata K, Kato-Hayashi H, Watanabe D, Ishihara T, Uemura S, Iwashita T, Imai H, Matsuhashi N, Takahashi T, Sugiyama T, Shimizu M, Yoshida K, Suzuki A.

Med Oncol. 2019 Jun 3;36(7):63. doi: 10.1007/s12032-019-1288-7.

PMID:
31161433
7.

Morphological and functional evaluation of the effect of novel pyrimidine derivatives on regeneration of the sciatic nerve in rats.

Raginov IS, Egorov VI, Valiullin LR, Watanabe D, Balakin KV, Murinov YI.

Neurosci Lett. 2019 Jul 27;706:110-113. doi: 10.1016/j.neulet.2019.05.008. Epub 2019 May 9.

PMID:
31078677
8.

Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy.

Yamada Y, Fujii H, Watanabe D, Kato-Hayashi H, Ohata K, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Shimizu M, Suzuki A.

Cancers (Basel). 2018 Nov 16;10(11). pii: E454. doi: 10.3390/cancers10110454.

9.

Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer.

Fujii H, Yamada Y, Watanabe D, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A.

Cancer Chemother Pharmacol. 2019 Jan;83(1):123-129. doi: 10.1007/s00280-018-3711-8. Epub 2018 Oct 30.

10.

Stretching After Heat But Not After Cold Decreases Contractures After Spinal Cord Injury in Rats.

Iwasawa H, Nomura M, Sakitani N, Watanabe K, Watanabe D, Moriyama H.

Clin Orthop Relat Res. 2016 Dec;474(12):2692-2701. Epub 2016 Aug 16.

Supplemental Content

Loading ...
Support Center